US 12053531
Materials and methods for treatment of Duchenne Muscular Dystrophy
granted A61KA61K35/28A61K35/34
Quick answer
US patent 12053531 (Materials and methods for treatment of Duchenne Muscular Dystrophy) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K35/28, A61K35/34, A61K38/465, A61K48/005